Quantum Dot Composite for Carrier Injection Balance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The imbalance of carrier injection in photoelectric devices leads to faster performance roll-off and shorter lifetimes of light-emitting devices.

Innovation Solution

A composite material comprising first quantum dots with N-type ligands and second quantum dots with P-type ligands, which are mixed at a specific ratio to form a light-emitting layer, improving carrier injection balance and extending the device's lifetime.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If quantum dot materials are used in photoelectric devices, then light emission performance is improved, but carrier injection imbalance occurs leading to shorter device lifetime

Engineering Contradiction:
Improvedevice lifetimeVSAvoidcarrier injection balance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent applies local quality by functionalizing different quantum dots with specific ligands (N-type for electron-rich, P-type for electron-deficient) to create localized charge characteristics. This allows different regions of the composite material to have specialized carrier injection properties, resolving the carrier injection imbalance problem while maintaining high light emission performance and extending device lifetime.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by combining first quantum dots with N-type ligands and second quantum dots with P-type ligands in a controlled molar ratio. This composite structure enables synergistic effects where the N-type and P-type quantum dots work together to balance carrier injection, simultaneously achieving improved reliability, maintained performance, and extended device lifetime.

Inventive Principle:
Principle #40Composite materials

2Duration of action of stationary object

If carrier injection balance is improved, then device lifetime is extended, but device complexity increases due to composite material structure

Engineering Contradiction:
Improvedevice lifetimeVSAvoidcomposite material structure
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by controlling the molar ratio of first to second quantum dots within a specific range (0.1 to 10, preferably 0.5 to 5). This parameter optimization allows the composite material to achieve carrier injection balance and extended device lifetime while maintaining manageable structural complexity through quantitative control rather than qualitative complexity.

Inventive Principle:
Principle #35Parameter changes

3Duration of action of moving object

If performance roll-off is slowed, then device lifetime is extended, but carrier injection balance must be improved first

Engineering Contradiction:
Improveperformance maintenance timeVSAvoidcarrier injection balance
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The patent applies preliminary action by pre-functionalizing quantum dots with appropriate ligands before assembling the composite material. This preliminary functionalization ensures that carrier injection balance is established at the material level before device operation, enabling sustained performance without rapid roll-off and extending the duration of effective operation.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250179350A1Composite material, and preparation method therefor, and light-emitting device
Publication Date: 2025.06.05 TCL TECHNOLOGY GROUP CORPORATION
  • US20250179350A1 patent drawing
  • US20250179350A1 patent drawing
  • US20250179350A1 patent drawing

AI summary

Disclosed in the present disclosure are a composite material, and a preparation method therefor, and a light-emitting device, and the composite material includes first quantum dots and second quantum dots, each of the first quantum dots have N-type ligands thereon, and each of the second quantum dots have P-type ligands thereon.